Cargando…

The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study

BACKGROUND: Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill human patients, including those with se...

Descripción completa

Detalles Bibliográficos
Autores principales: Meertens, John H., Nienhuis, Hans L., Lefrandt, Joop D., Schalkwijk, Casper G., Nyyssönen, Kristiina, Ligtenberg, Jack J. M., Smit, Andries J., Zijlstra, Jan G., Mulder, D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986948/
https://www.ncbi.nlm.nih.gov/pubmed/27529340
http://dx.doi.org/10.1371/journal.pone.0160893
_version_ 1782448244577533952
author Meertens, John H.
Nienhuis, Hans L.
Lefrandt, Joop D.
Schalkwijk, Casper G.
Nyyssönen, Kristiina
Ligtenberg, Jack J. M.
Smit, Andries J.
Zijlstra, Jan G.
Mulder, D. J.
author_facet Meertens, John H.
Nienhuis, Hans L.
Lefrandt, Joop D.
Schalkwijk, Casper G.
Nyyssönen, Kristiina
Ligtenberg, Jack J. M.
Smit, Andries J.
Zijlstra, Jan G.
Mulder, D. J.
author_sort Meertens, John H.
collection PubMed
description BACKGROUND: Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill human patients, including those with severe sepsis. OBJECTIVE: 1) To explore the reliability of Skin Autofluorescence (AF) as an index of tissue AGEs in ICU patients, 2) to compare its levels to healthy controls, 3) to describe the time course of AGEs and influencing factors during ICU admission, and 4) to explore their association with disease severity, outcome, and markers of oxidative stress and inflammation. METHODS: Skin AF, serum N"-(carboxyethyl)lysine (CEL), N"-(carboxymethyl)lysine (CML), and soluble RAGE (sRAGE) were serially measured for a maximum of 7 days in critically ill ICU patients with multiple organ failure and compared to age-matched healthy controls. Correlations with (changes in) clinical parameters of disease severity, LDL dienes, and CRP were studied and survival analysis for in-hospital mortality was performed. RESULTS: Forty-five ICU patients (age: 59±15 years; 60% male), and 37 healthy controls (59±14; 68%) were included. Skin AF measurements in ICU patients were reproducible (CV right-left arm: 13%, day-to-day: 10%), with confounding effects of skin reflectance and plasma bilirubin levels. Skin AF was higher in ICU patients vs healthy controls (2.7±0.7 vs 1.8±0.3 au; p<0.001). Serum CEL (23±10 vs, 16±3 nmol/gr protein; p<0.001), LDL dienes (19 (15–23) vs. 9 (8–11) μmol/mmol cholesterol; <0.001), and sRAGE (1547 (998–2496) vs. 1042 (824–1388) pg/ml; p = 0.003) were significantly higher in ICU patients compared to healthy controls, while CML was not different (27 (20–39) vs 29 (25–33) nmol/gr protein). While CRP and LDL dienes decreased significantly, Skin AF and serum AGEs and sRAGE did not change significantly during the first 7 days of ICU admission. CML and CEL were strongly correlated with SOFA scores and CML above the median at baseline was associated with increased risk for mortality (Hazard ratio 3.3 (1.3–8.3); p = 0.01). All other markers did not correlate with disease severity and did not predict mortality. CONCLUSIONS: This study demonstrates that markers for the AGE-RAGE axis are elevated in critically ill patients compared to healthy controls but remain stable for at least 7 days despite clearly fading inflammation and oxidative stress. Circulating AGEs may be associated with disease severity and outcome. Further research should be conducted to elucidate the role of the AGE-RAGE axis in the exaggerated inflammatory response leading to multiple organ failure and death, and whether or not this may be a target for treatment.
format Online
Article
Text
id pubmed-4986948
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49869482016-08-29 The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study Meertens, John H. Nienhuis, Hans L. Lefrandt, Joop D. Schalkwijk, Casper G. Nyyssönen, Kristiina Ligtenberg, Jack J. M. Smit, Andries J. Zijlstra, Jan G. Mulder, D. J. PLoS One Research Article BACKGROUND: Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill human patients, including those with severe sepsis. OBJECTIVE: 1) To explore the reliability of Skin Autofluorescence (AF) as an index of tissue AGEs in ICU patients, 2) to compare its levels to healthy controls, 3) to describe the time course of AGEs and influencing factors during ICU admission, and 4) to explore their association with disease severity, outcome, and markers of oxidative stress and inflammation. METHODS: Skin AF, serum N"-(carboxyethyl)lysine (CEL), N"-(carboxymethyl)lysine (CML), and soluble RAGE (sRAGE) were serially measured for a maximum of 7 days in critically ill ICU patients with multiple organ failure and compared to age-matched healthy controls. Correlations with (changes in) clinical parameters of disease severity, LDL dienes, and CRP were studied and survival analysis for in-hospital mortality was performed. RESULTS: Forty-five ICU patients (age: 59±15 years; 60% male), and 37 healthy controls (59±14; 68%) were included. Skin AF measurements in ICU patients were reproducible (CV right-left arm: 13%, day-to-day: 10%), with confounding effects of skin reflectance and plasma bilirubin levels. Skin AF was higher in ICU patients vs healthy controls (2.7±0.7 vs 1.8±0.3 au; p<0.001). Serum CEL (23±10 vs, 16±3 nmol/gr protein; p<0.001), LDL dienes (19 (15–23) vs. 9 (8–11) μmol/mmol cholesterol; <0.001), and sRAGE (1547 (998–2496) vs. 1042 (824–1388) pg/ml; p = 0.003) were significantly higher in ICU patients compared to healthy controls, while CML was not different (27 (20–39) vs 29 (25–33) nmol/gr protein). While CRP and LDL dienes decreased significantly, Skin AF and serum AGEs and sRAGE did not change significantly during the first 7 days of ICU admission. CML and CEL were strongly correlated with SOFA scores and CML above the median at baseline was associated with increased risk for mortality (Hazard ratio 3.3 (1.3–8.3); p = 0.01). All other markers did not correlate with disease severity and did not predict mortality. CONCLUSIONS: This study demonstrates that markers for the AGE-RAGE axis are elevated in critically ill patients compared to healthy controls but remain stable for at least 7 days despite clearly fading inflammation and oxidative stress. Circulating AGEs may be associated with disease severity and outcome. Further research should be conducted to elucidate the role of the AGE-RAGE axis in the exaggerated inflammatory response leading to multiple organ failure and death, and whether or not this may be a target for treatment. Public Library of Science 2016-08-16 /pmc/articles/PMC4986948/ /pubmed/27529340 http://dx.doi.org/10.1371/journal.pone.0160893 Text en © 2016 Meertens et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Meertens, John H.
Nienhuis, Hans L.
Lefrandt, Joop D.
Schalkwijk, Casper G.
Nyyssönen, Kristiina
Ligtenberg, Jack J. M.
Smit, Andries J.
Zijlstra, Jan G.
Mulder, D. J.
The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title_full The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title_fullStr The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title_full_unstemmed The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title_short The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
title_sort course of skin and serum biomarkers of advanced glycation endproducts and its association with oxidative stress, inflammation, disease severity, and mortality during icu admission in critically ill patients: results from a prospective pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986948/
https://www.ncbi.nlm.nih.gov/pubmed/27529340
http://dx.doi.org/10.1371/journal.pone.0160893
work_keys_str_mv AT meertensjohnh thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT nienhuishansl thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT lefrandtjoopd thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT schalkwijkcasperg thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT nyyssonenkristiina thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT ligtenbergjackjm thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT smitandriesj thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT zijlstrajang thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT mulderdj thecourseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT meertensjohnh courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT nienhuishansl courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT lefrandtjoopd courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT schalkwijkcasperg courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT nyyssonenkristiina courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT ligtenbergjackjm courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT smitandriesj courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT zijlstrajang courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy
AT mulderdj courseofskinandserumbiomarkersofadvancedglycationendproductsanditsassociationwithoxidativestressinflammationdiseaseseverityandmortalityduringicuadmissionincriticallyillpatientsresultsfromaprospectivepilotstudy